GC patients with high IL‐10 producing M2 infiltration exhibited a worse therapeutic response and a worse survival to adjuvant chemotherapy, which was characterized by increased Treg infiltration and CD8+ T‐cell malfunction. This evidence concerns the gene IL10 and gastric cancer.